Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.
ļ»æ

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Mayo Clinic Ranks First In Hospital AI šŸš€Bart likes this
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(12)
•••
Comment by jopatcloon Jul 31, 2024 7:57am
73 Views
Post# 36155767

RE:Mayo Clinic Ranks First In Hospital AI šŸš€Bart likes this

RE:Mayo Clinic Ranks First In Hospital AI šŸš€Bart likes this
jopatclo wrote: Interesting
Barts profile photo
Bart Hendriks likes this
A great testament to the tremendous efforts @mayoclinic is investing in advancing AI discovery and bringing it into everyday patient care. Also an important reason I’m happy and proud to work at Mayo Clinic


good comment @cardinal When the huge clinics buy, they all buy. Exciting time..: great deal atm

FDA V4.0 or clinics buy ? Insiders know! news anytime now Ventripoint denigrator team with several fake accounts working hard, good indicator of news to come. Go to Dr. Adams the visionary for FDA V4.0 or Sales?
FDA V4.0 or clinics buy ? Insiders know! news anytime now Ventripoint denigrator team with several fake accounts working hard, good indicator of news to come. Go to Dr. Adams the visionary for FDA V4.0 or Sales? 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities